PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Personalis, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$15.88+0.23 (+1.47%)
Close on Oct 19, 2026
- Market cap
- $1.67B
- P/E (TTM)
- –
- Dividend yield
- –
Personalis statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Personalis | Industry median |
|---|---|---|
| Market Cap | $1.70B | $1.14B |
| Enterprise Value | $1.48B | $1.35B |
| PS Ratio | 24.34 | 1.63 |
| PB Ratio | 7.21 | 3.03 |
| P/TBV Ratio | 7.21 | 4.99 |
Enterprise value
| Measure | Personalis | Industry median |
|---|---|---|
| EV / Sales | 21.29 | 1.78 |
Income (trailing twelve months)
| Measure | Personalis | Industry median |
|---|---|---|
| Revenue | $69.67M | $561.90M |
| Gross Profit | $8.84M | $173.32M |
| Operating Income | -$114.31M | -$1.81M |
| Pretax Income | -$107.15M | -$572.42K |
| Net Income | -$107.18M | -$1.16M |
| EBITDA | -$104.66M | -$20.72K |
| EPS (Diluted) | -$1.09 | -$0.02 |
Margins
| Measure | Personalis | Industry median |
|---|---|---|
| Gross Margin | 12.7% | 33.1% |
| Operating Margin | -164.1% | -4.45% |
| Pretax Margin | -153.8% | 1.54% |
| Profit Margin | -153.8% | -2.91% |
| EBITDA Margin | -150.2% | 2.41% |
| FCF Margin | -144.9% | 3.13% |
Returns
| Measure | Personalis | Industry median |
|---|---|---|
| Return on Equity (ROE) | -50.3% | 1.84% |
| Return on Assets (ROA) | -37.6% | -3.06% |
| Return on Invested Capital (ROIC) | -450.4% | 2.11% |
| Return on Capital Employed (ROCE) | -43.0% | -0.57% |
Growth
| Measure | Personalis | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -13.3% | 6.92% |
| Revenue Growth (3Y CAGR) | 2.30% | 10.9% |
| Revenue Growth (5Y CAGR) | -2.40% | 13.2% |
Balance sheet
| Measure | Personalis | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $212.66M | $48.71M |
| Net Cash (Debt) | $212.66M | $205.49K |
| Net Cash Per Share | $1.99 | $0.01 |
| Equity (Book Value) | $235.16M | $235.16M |
| Book Value Per Share | $2.20 | $3.48 |
| Tangible Book Value | $235.16M | $703.69K |
| Working Capital | $198.67M | $30.48M |
Financial position
| Measure | Personalis | Industry median |
|---|---|---|
| Current Ratio | 5.28 | 1.40 |
| Quick Ratio | 4.91 | 1.02 |
| Interest Coverage | -536.66 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Personalis | Industry median |
|---|---|---|
| Operating Cash Flow | -$92.30M | $3.10M |
| Capital Expenditures | -$8.68M | -$18.62M |
| Free Cash Flow | -$100.98M | $23.73M |
| FCF Per Share | -$0.95 | $0.37 |
Efficiency
| Measure | Personalis | Industry median |
|---|---|---|
| Asset Turnover | 0.24 | 0.87 |
| Revenue Per Employee | $267.96K | $228.48K |
| Profits Per Employee | -$412.23K | -$8.65K |
| Employee Count | 260 | 913 |
Dividends and yields
| Measure | Personalis | Industry median |
|---|---|---|
| Earnings Yield | -6.32% | -1.25% |
| FCF Yield | -5.95% | 1.74% |
| Buyback Yield | -7.93% | 0.32% |
| Shareholder Yield | -7.93% | 0.65% |
Shares
| Measure | Personalis | Industry median |
|---|---|---|
| Shares Outstanding | 106,800,000 | 58,282,400 |
| Shares Change (YoY) | 26.0% | 2.68% |
| Shares Change (QoQ) | 1.60% | 0.32% |
| Float | 90,699,400 | 33,780,100 |
| Shares Held by Insiders | 15.1% | 16.4% |
| Shares Held by Institutions | 79.6% | 85.9% |
Taxes
| Measure | Personalis | Industry median |
|---|---|---|
| Income Tax | $33.00K | $697.00K |
Scores
| Measure | Personalis | Industry median |
|---|---|---|
| Altman Z-Score | 9.89 | 1.96 |
| Piotroski F-Score | 4 | 5 |
| Beneish M-Score | -1.33 | -2.71 |
Calculated by StockData from Personalis's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.